ENT Diagnostics and Therapeutics

ENT Infections and Antimicrobial Resistance

This track will focus on the diagnosis, treatment, and prevention of common ENT infections including acute otitis media, sinusitis, pharyngitis, and mastoiditis. A significant focus will be on antibiotic stewardship, resistance trends, and the development of alternative therapies such as probiotics and bacteriophages.Clinicians, microbiologists, and infectious disease specialists will gain insight into safer, more effective infection control in ENT practice.The session will also highlight emerging pathogens and their clinical impact, with updates on diagnostic tools such as rapid antigen testing, PCR assays, and imaging advancements for deep neck space infections. Discussions will address post-COVID complications like long-term anosmia and secondary ENT infections, and their appropriate management. Global case studies will offer perspectives on region-specific resistance patterns and the challenges of overprescription. Attendees will explore guidelines for empirical therapy, duration of antibiotic use, and infection prevention in surgical ENT settings. The role of vaccines, immunotherapy, and host microbiome modulation in reducing infection incidence will also be explored. This track aims to support informed, evidence-based decisions that curb antimicrobial resistance while improving patient outcomes.